Arg213

Site Information
NFGFGDsrGGGGNFG SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 6009291

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 )
Disease tissue studied:	testicular cancer ( 22 , 23 )
Relevant cell line - cell type - tissue:	'brain, embryonic' ( 39 ) , brain ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 38 ) , embryo ( 1 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 ) , F9 (testicular) ( 23 ) , heart ( 40 ) , kidney ( 24 , 26 ) , liver ( 41 ) , lung ( 25 , 27 ) , MEF (fibroblast) ( 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ) , P19 (testicular) ( 22 ) , PYS-2 (epithelial) ( 21 )

References
1	Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87 24129315 Curated Info
2	Guo A (2013) CST Curation Set: 18332; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
3	Guo A (2013) CST Curation Set: 18333; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
4	Guo A (2013) CST Curation Set: 18334; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
5	Guo A (2013) CST Curation Set: 18335; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
6	Guo A (2013) CST Curation Set: 18336; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
7	Guo A (2013) CST Curation Set: 18337; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
8	Guo A (2013) CST Curation Set: 18338; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
9	Guo A (2013) CST Curation Set: 18339; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
10	Guo A (2013) CST Curation Set: 18340; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
11	Guo A (2013) CST Curation Set: 18341; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
12	Guo A (2013) CST Curation Set: 18342; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
13	Guo A (2013) CST Curation Set: 18343; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
14	Guo A (2013) CST Curation Set: 18344; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
15	Guo A (2013) CST Curation Set: 18345; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
16	Guo A (2013) CST Curation Set: 18346; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
17	Guo A (2013) CST Curation Set: 18347; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
18	Guo A (2013) CST Curation Set: 18348; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
19	Guo A (2013) CST Curation Set: 18349; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
20	Zhou J (2010) CST Curation Set: 9110; Year: 2010; Biosample/Treatment: cell line, ES J1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
21	Zhou J (2010) CST Curation Set: 9115; Year: 2010; Biosample/Treatment: cell line, PY2/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
22	Zhou J (2010) CST Curation Set: 9114; Year: 2010; Biosample/Treatment: cell line, P19/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
23	Zhou J (2010) CST Curation Set: 9111; Year: 2010; Biosample/Treatment: cell line, F9/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
24	Zhou J (2009) CST Curation Set: 7948; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
25	Zhou J (2009) CST Curation Set: 7946; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
26	Zhou J (2009) CST Curation Set: 7947; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
27	Zhou J (2009) CST Curation Set: 7945; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
28	Zhou J (2009) CST Curation Set: 6953; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
29	Zhou J (2009) CST Curation Set: 6952; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
30	Zhou J (2009) CST Curation Set: 6955; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
31	Zhou J (2009) CST Curation Set: 6954; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
32	Zhou J (2009) CST Curation Set: 6011; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
33	Zhou J (2009) CST Curation Set: 6009; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
34	Zhou J (2009) CST Curation Set: 6008; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
35	Zhou J (2009) CST Curation Set: 6014; Year: 2012; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
36	Rikova K (2008) CST Curation Set: 4939; Year: 2008; Biosample/Treatment: cell line, Dana Farber-S1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
37	Rikova K (2008) CST Curation Set: 4937; Year: 2008; Biosample/Treatment: cell line, Dana Farber-L1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
38	Zhou J (2008) CST Curation Set: 3811; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
39	Zhou J (2008) CST Curation Set: 3812; Year: 2008; Biosample/Treatment: tissue, brain, embryonic/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
40	Zhou J (2008) CST Curation Set: 3813; Year: 2008; Biosample/Treatment: tissue, heart/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
41	Zhou J (2008) CST Curation Set: 3814; Year: 2008; Biosample/Treatment: tissue, liver/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info